About Astraazin Pharmaceuticals Private Limited
Data last updated:
Astraazin Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2014PTC270145. Its GSTIN is 07AANCA0386K1ZD (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Riyaz Ahmad Wani (Managing Director) and Seerat Riyaz.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 150 Vardhman Crown Mall Plot No. – 2 Sector – 19 Dwarka, New Delhi, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹4 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹9.65 Lakh (net margin 2.4%) and EBITDA of ₹14.51 Lakh (EBITDA margin 3.6%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
The company has about 24 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Astraazin Pharmaceuticals. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website astraazin.com.
Company details
Contact details
Astraazin Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is astraazin.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address150 Vardhman Crown Mall Plot No. – 2 Sector – 19 Dwarka, New Delhi, Delhi, India – 110075
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Astraazin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Astraazin Pharmaceuticals operates one associated brand: Astraazin Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and medicinal product services in India. | astraazin.com |
Business activity
The main business activity of Astraazin Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Astraazin Pharmaceuticals Private Limited, buy the company report.
Financials of Astraazin Pharmaceuticals Private Limited
FY 2025 filings availableAstraazin Pharmaceuticals Private Limited reported revenue of ₹4 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.51 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.65 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.6% | ||||
| Net Profit Margin | 2.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astraazin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Astraazin Pharmaceuticals Private Limited
Astraazin Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seerat Riyaz | Director | 08 Aug 2014 | 12 Years 3 Months | Current |
| Riyaz Ahmad Wani Also directs: Weitz Biosciences Private Limited | Managing Director | 08 Aug 2014 | 12 Years 3 Months | Current |
Peer comparison
Astraazin Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Verlen Labs Private Limited | ₹4.01 Cr (FY 2024) | -18.0% | Secunderabad, Telangana, India | |||
| Amraph India Private Limited | ₹4.01 Cr (FY 2024) | 31.0% | New Delhi, Delhi, India | |||
| Chiron Pharmaceuticals Private Limited | ₹4 Cr (FY 2024) | 11.0% | Chennai, Tamil Nadu, India | |||
| Cure Quick Remedies Private Limited | ₹4 Cr (FY 2025) | -42.0% | Haryana, India | |||
| Astraazin Pharmaceuticals Private Limitedthis company | ₹4 Cr (FY 2025) | ₹9.65 Lakh | 2.4% | -6.0% | 24 | New Delhi, Delhi, India |
| Aslan Healthcare Private Limited | ₹3.99 Cr (FY 2024) | -7.0% | New Delhi, Delhi, India | |||
| Winlyn Healthcare Private Limited | ₹3.98 Cr (FY 2024) | -1.0% | Gurgaon, Haryana, India |
To see the full peer comparison of Astraazin Pharmaceuticals Private Limited, buy the company report.
Auditor
Astraazin Pharmaceuticals Private Limited is audited by Vikas Chauhan & Associates for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vikas Chauhan & Associates | FY 2021 | 031553N |
Shareholding
The shareholding of Astraazin Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Astraazin Pharmaceuticals Private Limited, buy the company report.
Legal cases
Astraazin Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Srinagar, Jammu and Kashmir | Court case (Complaint) | Filed against the company | Pending |
To see the full case history of Astraazin Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astraazin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Astraazin Pharmaceuticals Private Limited has a workforce of 24 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 24 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 |
To see the full employee and EPFO history of Astraazin Pharmaceuticals Private Limited, buy the company report.
GST
Astraazin Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AANCA0386K1ZD | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Astraazin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Astraazin Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Riyaz Ahmad Wani was appointed as Managing Director on 08 Aug 2014.
Frequently asked questions
Astraazin Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 August 2014 (12+ years old) and is registered under CIN U24239DL2014PTC270145.
Astraazin Pharmaceuticals has 2 current directors:
- Riyaz Ahmad Wani - Managing Director
- Seerat Riyaz - Director
The latest financial statements of Astraazin Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Astraazin Pharmaceuticals is 07AANCA0386K1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Astraazin Pharmaceuticals is U24239DL2014PTC270145. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astraazin Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Astraazin Pharmaceuticals was incorporated on 08 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Astraazin Pharmaceuticals by revenue are Verlen Labs Private Limited, Amraph India Private Limited, Chiron Pharmaceuticals Private Limited, Cure Quick Remedies Private Limited, Aslan Healthcare Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Riyaz Ahmad Wani was appointed as Managing Director on 08 Aug 2014. Seerat Riyaz was appointed as Director on 08 Aug 2014.
Astraazin Pharmaceuticals can be reached through the website astraazin.com. Its registered office is in New Delhi, Delhi, India.
The registered office of Astraazin Pharmaceuticals is at 150 Vardhman Crown Mall Plot No. – 2 Sector – 19 Dwarka, New Delhi, Delhi, India – 110075.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
